drugset / Trial / NCT00368394
Dose-Exposure-Response in Type 1 Diabetes Mellitus
RandomizedCrossoverSingle-blindTreatment
Summary
To investigate the dose-exposure-response relationship of insulin glulisine (HMR1964) after single subcutaneous injections of 0.075, 0.15 and 0.3 U/kg body weight with the euglycaemic clamp technique using the Biostator (TM).
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | 0.075 unknown | Subcutaneous |
| Subject | Insulin glulisine | Protein / enzyme biologic | 0.15 unknown | Subcutaneous |
| Subject | Insulin glulisine | Protein / enzyme biologic | 0.3 unknown | Subcutaneous |